Impact of radioiodine treatment on acute phase proteins in hyperthyroid cats

J Feline Med Surg. 2022 Apr;24(4):359-365. doi: 10.1177/1098612X211024954. Epub 2021 Jul 27.

Abstract

Objectives: The aim of this study was to investigate the impact of radioiodine treatment (RIT) on the acute phase proteins (APPs) serum amyloid A (SAA), alpha-1-acid glycoprotein (AGP) and haptoglobin (Hp) in hyperthyroid cats.

Methods: Between June 2013 and November 2014, 33 hyperthyroid cats without clinical or laboratory signs of inflammatory or neoplastic disease and a body weight >2.5 kg were enrolled. Immediately before, and 12, 36, 72 h and 6 days after RIT, serum samples were obtained for determination of APP concentrations.

Results: Both SAA and AGP concentrations changed significantly after RIT. The concentration of AGP increased gradually after treatment with a maximum concentration at the end of the study period (median baseline 398 μg/ml; median 6 days post-RIT 562 μg/ml [P = 0.001]). A relevant >two-fold increase in AGP was seen in 8/33 (24%) cats. SAA concentration increased significantly within 12 h (baseline 9.2 μg/ml; 12 h post-RIT 22.5 μg/ml [P = 0.012]). In 7/33 (21%) cats, a clinically relevant >10-fold increase in SAA was observed. Hp concentration showed no significant change (P = 0.12).

Conclusions and relevance: RIT induced a mild, mainly not clinically relevant acute phase reaction (APR). AGP and SAA were useful APPs to determine RIT-induced APR.

Keywords: Acute phase reaction; alpha-1-acid glycoprotein; endocrine; serum amyloid A.

MeSH terms

  • Acute-Phase Proteins
  • Animals
  • Cat Diseases* / radiotherapy
  • Cats
  • Hyperthyroidism* / radiotherapy
  • Hyperthyroidism* / veterinary
  • Iodine Radioisotopes / therapeutic use
  • Orosomucoid / metabolism
  • Serum Amyloid A Protein / metabolism

Substances

  • Acute-Phase Proteins
  • Iodine Radioisotopes
  • Orosomucoid
  • Serum Amyloid A Protein